CD24 and neoplasm: Conversely, in ovarian cancer and triple-negative breast cancer (TNBC), sialylated CD24 on the surface of tumor cells serves as a “don’t eat me” signal by binding to Siglec-10 on macrophages, thereby preventing the clearance of cancer cells and facilitating tumor progression [3].